Climate change could raise risk of congenital heart defects
(Reuters Health) – More babies could be born with heart defects in the future as global warming puts pregnant women at greater risk of exposure to dangerously high temperatures, new…
by October Gallery
(Reuters Health) – More babies could be born with heart defects in the future as global warming puts pregnant women at greater risk of exposure to dangerously high temperatures, new…
TOKYO (Reuters) – Japanese doctor Yasushi Goto remembers prescribing the cancer drug Opdivo to an octogenarian and wondering whether taxpayers might object to helping fund treatment, which at the time…
FILE PHOTO: A Payless ShoeSource store logo is pictured in the Manhattan borough of New York, New York, U.S. April 4, 2017. REUTERS/Carlo Allegri/File Photo (Reuters) – U.S. discount retailer…
PARIS (Reuters) – Only half of France’s farmland could do without glyphosate-based weed-killers by 2021, the country’s farm minister suggested, further lowering an initial ambition to get rid of the…
(Reuters Health) – A six-month program of aggressively washing and sanitizing at home after surgery can lower the risk of developing a potentially-deadly infection for people who harbor the antibiotic-resistant…
(Reuters Health) – People who eat a lot of animal protein may be more likely to have excessive fat in their livers and a higher risk of liver disease than…
FILE PHOTO: The Merck logo is seen at a gate to the Merck & Co campus in Linden, New Jersey, U.S., July 12, 2018. REUTERS/Brendan McDermid NEW YORK (Reuters) –…
(Reuters) – Seven adult detainees at a U.S. Immigration and Customs Enforcement detention facility in Houston have been diagnosed with mumps, but the contagious disease is contained, the city’s health…
FILE PHOTO: A Johnson & Johnson building is shown in Irvine, California, U.S., January 24, 2017. REUTERS/Mike Blake/File Photo CHICAGO (Reuters) – Johnson & Johnson said on Thursday it will…
(Reuters) – The U.S. Food and Drug Administration (FDA) said on Wednesday it had approved Sanofi SA’s drug to treat a rare blood-clotting disorder in adults in combination with standard-of-care…